NCT02770404View on ClinicalTrials.gov

A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 25, 2016

Primary Completion Date

October 25, 2016

Study Completion Date

December 25, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

Nafithromycin

100, 200, or 400 mg of nafithromycin

DRUG

Placebo

IV matching placebo

Trial Locations (1)

53095

Phase 1 unit : Spaulding Clinical Research, LLC, West Bend

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY